Results 211 to 220 of about 127,469 (270)
Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies. [PDF]
Carvalho E+3 more
europepmc +1 more source
Abstract Background The optimal strategy for modern chemotherapy should be based on a comprehensive approach for cancer patients with cardiovascular diseases. Therefore, cardio‐oncology has received increasing attention owing to the cardiotoxic effects of anti‐cancer therapies.
Tomiko Sunaga+7 more
wiley +1 more source
Sex difference in TRPM3 channel functioning in nociceptive and vascular systems: an emerging target for migraine therapy in females? [PDF]
Krivoshein G+4 more
europepmc +1 more source
Association of ventricular–arterial coupling with heart failure (HF) biomarkers in the STANISLAS cohort. MMP, matrix metalloproteinase; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Aims Impaired left ventricular–arterial coupling (VAC) has been shown to correlate with worse prognosis in cardiac diseases and heart failure (HF).
Hannes Holm+12 more
wiley +1 more source
The causal impact of bioavailable testosterone levels on osteoarthritis: a bidirectional Mendelian randomized study. [PDF]
Jiang Z+6 more
europepmc +1 more source
Linking guideline‐directed medical therapy (GDMT) implementation and appropriate polypharmacy management in heart failure (HF). Polypharmacy can represent a barrier to the proper implementation of life‐prolonging GDMT for HF. A reasonable balance between the optimization of GDMT and avoiding inappropriate polypharmacy is mandatory in the contemporary ...
Davide Stolfo+27 more
wiley +1 more source
Octamethylcyclotetrasiloxane (D4) lacks endocrine disruptive potential via estrogen pathways. [PDF]
Borgert CJ, Burgoon LD.
europepmc +1 more source
The monthly rhythm of the brain-heart connection. [PDF]
Prinsen J, Villringer A, Sacher J.
europepmc +1 more source
Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms. [PDF]
Hassan M+11 more
europepmc +1 more source
Hormone replacement therapy in surgical menopause after gynecological malignancies. [PDF]
Tomić Naglić D+9 more
europepmc +1 more source